stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Dow:  
Nasdaq:  
S&P 500:  
Embecta CorpEMBC
$6.220.56%-0.035

Embecta Corp (EMBC)

Date: 2026-11-02 16:00O: 6.32H: 6.36L: 6.14C: 6.22Vol: 288.2k
Embecta Corp stock is traded at $6.22, with a volume of 318,823. It is down -0.56% in the last 24 hours and up +10.00% over the past month. Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Previous Close:
$6.25
Open:
$6.32
24h Volume:
318,823
Relative Volume:
0.36
Market Cap:
$352.14M
Revenue:
$1.04B
Net Income/Loss:
$111.90M
P/E Ratio:
3.15
EPS:
$1.97
Net Cash Flow:
$205.80M
1W Performance:
-8.60%
1M Performance:
+10.00%
6M Performance:
-32.67%
1Y Performance:
-53.41%
1-Day Range:
$6.14$6.36
1-Week Range:
$6.20$6.90
52-Week Range:
$2.77$14.91

Embecta Corp Stock (EMBC) Company Profile

Name
Embecta Corp
Phone
(862) 401-0000
Address
300 KIMBALL DRIVE, PARSIPPANY, USA
Employee
1,850
X
-
Next Earnings Date
2026-11-24
Latest SEC Filings
SEC
EMBC's Discussions on X
X

Compare EMBC vs ISRG, BDX, ALC, RMD, MDLN

StocksMarket CapRevenueNet IncomeCash FlowEPS
EMBC
Embecta Corp
$352.14M$1.02B$87.50M$205.80M$1.97
ISRG
Intuitive Surgical Inc
$156.01B$11.58B$2.96B$3.22B$8.73
BDX
Becton Dickinson Co
$54.42B$20.84B$941.00M$3.07B$3.94
ALC
Alcon Inc
$35.74B$224.23M-$39.99M$1.59B$1.66
RMD
Resmed Inc
$32.81B$5.73B$1.59B$1.74B$10.37
MDLN
Medline Inc
$29.43B$29.14B$1.07B$1.05B$1.20

Embecta Corp Stock (EMBC) Upgrades & Downgrades

DateActionAnalystRating Change
May-06-26DowngradeBTIG ResearchBuy → Neutral
Apr-10-25InitiatedMizuhoNeutral
Dec-02-24UpgradeMorgan StanleyUnderweight → Equal-Weight
Nov-27-24UpgradeBTIG ResearchNeutral → Buy

Embecta Corp Stock (EMBC) Financials Data

PeriodTrendFY 2025FY 2024FY 2023FY 2022
Period End Date2025-09-302024-09-302023-09-302022-09-30
Revenue USD (M)1,080.401,123.101,120.801,129.50
Cost of revenue USD (M)403.60387.90370.90354.60
Gross profit USD (M)676.80735.20749.90774.90
Research and development USD (M)37.3078.8085.2066.90
Operating expenses USD (M)434.70568.40528.40465.30
Operating income USD (M)242.10166.80221.50309.60
Income before tax USD (M)136.3044.20105.70256.60
Income tax expense USD (M)40.90-34.1035.3033.00
Net income USD (M)95.4078.3070.40223.60
Basic EPS USD/shares1.641.361.233.92
Diluted EPS USD/shares1.621.341.223.89
Basic weighted shares shares (M)58.3157.6857.2557.02
Diluted weighted shares shares (M)58.9258.3357.7657.46
Selling, general and administrative USD (M)332.00365.10341.30294.80

Embecta Corp Stock (EMBC) Insider Trading

  • Director
    Transaction
    Proposed Sale
    Cost
    $5.86
    #Shares
    6,293
    Value ($)
    36,891
    #Shares Total
    0
  • President and CEO
    Transaction
    Buy
    Cost
    $4.70
    #Shares
    30,000
    Value ($)
    140,937
    #Shares Total
    804,919
  • Elguicze JacobAug 12 '26
    SVP and CFO
    Transaction
    Buy
    Cost
    $4.67
    #Shares
    20,000
    Value ($)
    93,360
    #Shares Total
    309,139
  • Mann Jeffrey ZAug 12 '26
    Pres, Pharm Svc&Prod Mgmt, CLO
    Transaction
    Buy
    Cost
    $4.99
    #Shares
    20,000
    Value ($)
    99,800
    #Shares Total
    262,915
  • Director
    Transaction
    Buy
    Cost
    $4.97
    #Shares
    45,000
    Value ($)
    223,848
    #Shares Total
    109,587
Insider TradingRelationshipDateTransactionCost#SharesValue ($)#Shares Total
Morris Milton MayoDirectorSep 04 '26Proposed Sale$5.866,29336,8910
Kurdikar DevdattPresident and CEOAug 12 '26Buy$4.7030,000140,937804,919
Elguicze JacobSVP and CFOAug 12 '26Buy$4.6720,00093,360309,139
Mann Jeffrey ZPres, Pharm Svc&Prod Mgmt, CLOAug 12 '26Buy$4.9920,00099,800262,915
HOMBACH ROBERT J.DirectorAug 12 '26Buy$4.9745,000223,848109,587

Embecta Corp Stock (EMBC) Latest News

Sep 22, 2026
Sep 22, 2026
Sep 11, 2026
Sep 11, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 07, 2026
Sep 07, 2026
Sep 04, 2026
Sep 04, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 02, 2026
Sep 02, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 30, 2026
Aug 30, 2026
Aug 26, 2026
Aug 26, 2026
Aug 24, 2026
Aug 24, 2026
Aug 24, 2026
Aug 24, 2026
Aug 22, 2026
Aug 22, 2026
Aug 21, 2026
Aug 21, 2026
Aug 21, 2026
Aug 21, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 16, 2026
Aug 16, 2026
Aug 16, 2026
Aug 16, 2026
Aug 16, 2026
Aug 16, 2026
Aug 16, 2026
Aug 16, 2026
Aug 16, 2026
Aug 16, 2026
Aug 15, 2026
Aug 15, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026

Similar to EMBC